Publication: Imatinib mesylate reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukemia
Program
KU-Authors
KU Authors
Co-Authors
Şimşek, Eda Tanrıkulu
Eskazan, Ahmet Emre
Cengiz, Mahir
Ar, M. Cem
Ekizoğlu, Seda
Salihoğlu, Ayşe
Gültürk, Emine
Elverdi, Tuğrul
Aydın, Seniz Öngören
Demiröz, Ahu Senem
Date
Language
Type
Embargo Status
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Source
Publisher
American Society Hematology
Keywords
Hematology
Citation
Has Part
Source
Blood